Metabolomic profiling of renal cell carcinoma to identify prognostic markers of metastasis
PLOS One · 11.11.2026 · 21 (11) · e0361404
DOI: 10.1371/journal.pone.0361404 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 11.11.2026. Verfasst von Michael Williams und 11 weiteren Autor:innen. Beteiligte Einrichtung: Urology of Virginia, Virginia Beach, and Department of Urology, Virginia Health Sciences at Old Dominion University, Norfolk, Virginia, United States…. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Metabolomics, Biomarkers, Tumor. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Division of Cancer Epidemiology and Genetics, National Cancer Institute.
Abstract (Originalsprache)
Background
Patients with clear cell renal cell carcinoma (ccRCC) undergo surveillance for recurrent or metastatic disease following nephrectomy. The primary aim of this study was identification of prognostic biomarkers for metastatic disease.
Methods
We conducted a retrospective case control study of ccRCC patients treated with surgical resection. At 3 years follow up tumors were classified as cases or non-metastatic tumors based on presence or absence of metastases. Fresh frozen ccRCC tumors and adjacent normal tissues were analyzed by combining a chemical labeling method with liquid chromatography-mass spectrometry (LC-MS). Three different chemical groups were analyzed: Carboxyl, Amine-Phenol, and Hydroxyl. Metabolites were identified using a chemical library for cross-reference. LC-MS results were analyzed with machine learning approaches and statistical models. Unsupervised machine learning (UMAP, Non-negative Matrix Factorization) was used for exploratory analysis of the data. Supervised machine learning, using both linear and nonlinear Support Vector Machines (SVM), was used to construct classification models. Repeated cross-validation was used to avoid overfitting and gain representative classification performance of the model.
Results
Machine learning and SVM classification models showed good classification performance with an area under the Precision-Recall curve (AUPRC) of 0.92 for the best-performing model. Metabolites showing statistically significant changes associated with metastasis included the following: 4-Hydroxybutanoic acid, Glutamyl-Glutamic acid, 3-Aminosalicylic acid, Indoxyl sulfate, 3,4-Dihydroxyphenylpropanoic acid, and N-ethylglycine.
Conclusions
Metabolites which are prognostic for ccRCC metastasis were identified. Impact: Prognostic biomarkers could inform the frequency and intensity of post-operative surveillance of ccRCC. Identification of such biomarkers could aid clinicians in the management of patients with ccRCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Urology of Virginia, Virginia Beach, and Department of Urology, Virginia Health Sciences at Old Dominion University, Norfolk, Virginia, United States of America.
- Joint School of Public Health, Old Dominion University and Norfolk State University, Norfolk, Virginia, United States of America.
- Leroy T. Canoles Jr. Cancer Research Center and Office of Research, Norfolk, Virginia, United States of America.
- Department of Chemistry, University of Alberta, Edmonton, Alberta, Canada.
- Aspect Analytics NV, Genk, Belgium.
- Virginia Health Sciences at Old Dominion University, Norfolk, Virginia, United States of America.
ORCID-Profile: Aditya Chakraborty, Dean Troyer
Förderung
- Division of Cancer Epidemiology and Genetics, National Cancer Institute
Zitieren
APA
Williams, M., Chakraborty, A., Main, B., Li, L., Chan, Y. C., Wang, X., Verbeeck, N., Spiers, L., Routten, O., Chin, T., Bejar, K., & Troyer, D. (2026). Metabolomic profiling of renal cell carcinoma to identify prognostic markers of metastasis. PLOS One, 21(11), e0361404. https://doi.org/10.1371/journal.pone.0361404
Vancouver
Williams M, Chakraborty A, Main B, Li L, Chan YC, Wang X, et al. Metabolomic profiling of renal cell carcinoma to identify prognostic markers of metastasis. PLOS One. 2026;21(11):e0361404. doi:10.1371/journal.pone.0361404
BibTeX
@article{Williams2026,
author = {Williams, Michael and Chakraborty, Aditya and Main, Brian and Li, Liang and Chan, Ya-Chun and Wang, Xiaohang and Verbeeck, Nico and Spiers, Liam and Routten, Olivia and Chin, Theodore and Bejar, Kaitlyn and Troyer, Dean},
title = {Metabolomic profiling of renal cell carcinoma to identify prognostic markers of metastasis},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {11},
pages = {e0361404},
doi = {10.1371/journal.pone.0361404}
}
EUVIMED